ResMed RMD Income Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $1.52B+15.7% | $1.49B+19.0% | $1.44B+29.2% | $1.4B+37.2% | $1.31B+37.0% | ||
| $2.11B+18.0% | $2.02B+16.4% | $1.95B+22.0% | $1.88B+25.9% | $1.79B+28.5% | ||
| $1.89B+17.4% | $1.82B+16.6% | $1.74B+23.0% | $1.69B+27.7% | $1.61B+32.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is ResMed's revenue?
- ResMed (RMD) generated $5.5B in revenue over the trailing twelve months, up 10.3% year over year.
- Is ResMed profitable?
- ResMed reported $1.5B in net income over the trailing twelve months, a 27.4% net margin.
- What are ResMed's profit margins?
- Gross margin is 61.6% and operating margin is 34.2%, with a 27.4% net margin.
- What is ResMed's earnings per share?
- ResMed's diluted EPS over the trailing twelve months is $10.37.
- Where does ResMed's income statement data come from?
- Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
